Astera Labs (NASDAQ:ALAB) Shares Down 4.2% After Insider Selling

Key Points

• Astra Labs' stock price fell by 4.2% after General Counsel Philip Mazzara sold 10,000 shares at an average price of $192.16, resulting in a total sale of $1.92 million.
• The company reported a 149.5% increase in revenue compared to the same quarter last year, with earnings per share of $0.44, exceeding analysts' expectations of $0.33.
• Astera Labs has seen varied ratings from analysts, with one "Strong Buy," fifteen "Buy," and seven "Hold" ratings, reflecting a general sentiment of moderate buy for the stock.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s stock price traded down 4.2% during trading on Friday after an insider sold shares in the company. The stock traded as low as $198.28 and last traded at $200.74. 5,167,101 shares traded hands during mid-day trading, an increase of 1% from the average session volume of 5,124,314 shares. The stock had previously closed at $209.60.

Specifically, General Counsel Philip Mazzara sold 10,000 shares of the business's stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the completion of the sale, the general counsel directly owned 151,573 shares in the company, valued at approximately $29,126,267.68. The trade was a 6.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on ALAB. CICC Research assumed coverage on shares of Astera Labs in a research note on Friday, August 29th. They set an "outperform" rating and a $190.00 target price on the stock. Susquehanna increased their target price on Astera Labs from $80.00 to $125.00 and gave the stock a "neutral" rating in a research report on Thursday, August 7th. Northland Capmk cut Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 22nd. Morgan Stanley increased their price objective on shares of Astera Labs from $155.00 to $200.00 and gave the company an "overweight" rating in a report on Friday, August 29th. Finally, Citigroup boosted their target price on shares of Astera Labs from $160.00 to $275.00 and gave the stock a "buy" rating in a report on Wednesday, September 17th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, Astera Labs has an average rating of "Moderate Buy" and an average price target of $159.83.

Astera Labs Stock Down 4.2%

The business's fifty day moving average is $189.83 and its two-hundred day moving average is $119.14. The stock has a market capitalization of $33.37 billion, a PE ratio of 358.46, a price-to-earnings-growth ratio of 5.32 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The firm had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. Astera Labs's revenue for the quarter was up 149.5% compared to the same quarter last year. During the same period last year, the firm posted $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Institutional Trading of Astera Labs

Institutional investors have recently bought and sold shares of the stock. Fred Alger Management LLC lifted its position in Astera Labs by 13.0% in the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after buying an additional 179,638 shares during the last quarter. Hoey Investments Inc. lifted its position in Astera Labs by 22.4% in the second quarter. Hoey Investments Inc. now owns 6,121 shares of the company's stock worth $553,000 after buying an additional 1,121 shares during the last quarter. Wealth Effects LLC bought a new stake in shares of Astera Labs during the second quarter worth $242,000. Sheets Smith Wealth Management bought a new stake in shares of Astera Labs during the second quarter worth $481,000. Finally, Aigen Investment Management LP lifted its position in shares of Astera Labs by 50.9% during the first quarter. Aigen Investment Management LP now owns 17,920 shares of the company's stock worth $1,069,000 after purchasing an additional 6,045 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.